DNAJC5 and malaria: CIS43 VLPs elicit high-titer antibody responses against P. falciparum CSP in both mice and macaques, particularly in combination with Advax adjuvants, these antibody responses are highly durable, and vaccination inhibits malaria invasion of the liver in a mouse model.